Profile of metastatic lung cancer patients susceptible to development of thromboembolism during immunotherapy
Open Access
- 10 March 2022
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 31, 100547
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and InflammationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Regression Shrinkage and Selection via The Lasso: A RetrospectiveJournal of the Royal Statistical Society Series B: Statistical Methodology, 2011
- The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2008
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis, 2007
- Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage studyJournal of Thrombosis and Haemostasis, 2006
- Chemotherapy-induced thrombosisThrombosis Research, 2006
- Risk factors for venous thromboembolic events in cancer patientsAnnals of Oncology, 2005
- Malignancies, Prothrombotic Mutations, and the Risk of Venous ThrombosisJAMA, 2005
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000